205 related articles for article (PubMed ID: 10935213)
1. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
Murase S; Saio M; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
Cancer Lett; 1998 Oct; 132(1-2):181-6. PubMed ID: 10397472
[TBL] [Abstract][Full Text] [Related]
3. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
4. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
Kara IO; Sahin B; Gunesacar R
Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
[TBL] [Abstract][Full Text] [Related]
5. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
Hintzen RQ; Paty D; Oger J
J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.
Geng M; Xiao H; Liu J; Song Y; Fu P; Cheng X; Zhang J; Wang G
Cancer Med; 2018 Aug; 7(8):3889-3898. PubMed ID: 29982995
[TBL] [Abstract][Full Text] [Related]
9. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome.
van der Vuurst de Vries RM; Mescheriakova JY; Runia TF; Jafari N; Siepman TA; Hintzen RQ
JAMA Neurol; 2017 Mar; 74(3):286-292. PubMed ID: 28055081
[TBL] [Abstract][Full Text] [Related]
11. The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.
Hottenrott T; Schorb E; Fritsch K; Dersch R; Berger B; Huzly D; Rauer S; Tebartz van Elst L; Endres D; Stich O
J Neurol; 2018 May; 265(5):1106-1114. PubMed ID: 29511863
[TBL] [Abstract][Full Text] [Related]
12. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
[TBL] [Abstract][Full Text] [Related]
13. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas.
Yalçin B; Canpinar H; Kutluk MT; Varan A; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2004 Dec; 21(8):717-23. PubMed ID: 15739627
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons.
Corcoran C; Rebe K; van der Plas H; Myer L; Hardie DR
J Clin Virol; 2008 Aug; 42(4):433-6. PubMed ID: 18455472
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
Baraniskin A; Chomiak M; Ahle G; Gress T; Buchholz M; Turewicz M; Eisenacher M; Margold M; Schlegel U; Schmiegel W; Hahn S; Schroers R
J Neurooncol; 2018 May; 137(3):463-468. PubMed ID: 29327175
[TBL] [Abstract][Full Text] [Related]
18. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.
Baraniskin A; Zaslavska E; Nöpel-Dünnebacke S; Ahle G; Seidel S; Schlegel U; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2016 Mar; 18(3):361-7. PubMed ID: 26250566
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.
Song Y; Zhang W; Zhang L; Wu W; Zhang Y; Han X; Yang C; Zhang L; Zhou D
Sci Rep; 2016 Dec; 6():38671. PubMed ID: 27924864
[TBL] [Abstract][Full Text] [Related]
20. Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus.
Font J; Pallares L; Martorell J; Martinez E; Gaya A; Vives J; Ingelmo M
Clin Immunol Immunopathol; 1996 Dec; 81(3):239-43. PubMed ID: 8938100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
